¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£¾ÏÇÐȸ APPLE 2023 (The 13th Asia-Pacific Primary Liver Cancer Expert Meeting) - Day1 : 2023-07-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑ°£¾ÏÇÐȸ APPLE 2023 (The 13th Asia-Pacific Primary Liver Cancer Expert Meeting) - Day1 : 2023-07-06
±³À°ÀÏÀÚ : 2023-07-06
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D

±³À°ÁÖÁ¦ : APPLE 2023 (The 13th Asia-Pacific Primary Liver Cancer Expert Meeting) - Day1

ÁÖÃÖ±â°ü : ´ëÇÑ°£¾ÏÇÐȸ
´ã´çÀÚ : Ȳ¼öÁ¤
¿¬¶ôó : 02-373-1005  

À̸ÞÀÏ : apple2023@hbni.co.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú

Âü¼®¿¹»óÀÎ : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 300,000¿ø

ºñ°í [Regular Registration-Non-Member Rate]Doctor, Healthcare Professionals: KRW 300,000 / USD 300Fellow, Resident, Researcher, Others: KRW 250,000 / USD 250Poster Presenter: KRW 100,000 / USD 100[Regular Registration-Member Rate]Doctor, Healthcare Professionals: KRW 250,000 / USD 250Fellow, Resident, Researcher, Others: KRW 200,000 / USD 200Poster Presenter: KRW 100,000 / USD 100


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 09:00~09:20 Changing Etiology and Epidemiology of HCC: Asia and Worldwide Do Young Kim(Yonsei Univ.)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 09:20~09:40 New Concepts in the Imaging Diagnosis of HCC: Can Artificial Intelligence Help? Chih-Hung Hsu(National Taiwan Univ., Taipei)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 09:40~10:00 Molecular Heterogeneity in HCC and the Challenge of Identifying Predictive Biomarkers Irene Ng(The Univ. of Hong Kong, Hong Kong)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 10:00~10:20 Adaptation of Practice Guidelines: When East Meets West Li-Tzong Chen(Kaohsiung Medical Univ., Kaohsiung)

Åä·Ð 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 10:20~10:35 Q&A Do Young Kim, Chih-Hung Hsu, Irene Ng, Li-Tzong Chen(Yonsei Univ., National Taiwan Univ., Taipei, The Univ. of Hong Kong, Hong Kong, Kaohsiung Medical Univ., Kaohsiung)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 10:50~11:10 Biomarker-Based New Drug Development in HCC Takahiro Kodama(Osaka Univ., Osaka)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 11:10~11:30 Translational Research: The Impact from Research in Epigenomics Jeon Ah Jung(Mirxes, Singapore)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 11:30~11:50 Translational Research: The Impact from Research in Spatial Transcriptomics Amkur Sharma(Harry Perkins Institute of Medical Research, Perth)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 11:50~12:10 The Promise of Immuno-Neoadjuvant Therapy in HCC Toh Han Chong(National Cancer Centre Singapore, Singapore)

Åä·Ð 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 12:10~12:25 Q&A Takahiro Kodama, Jeon Ah Jung, Amkur Sharma, Toh Han Chong(Osaka Univ., Osaka, Mirxes, Singapore, Harry Perkins Institute of Medical Research, Perth, National Cancer Centre Singapore, Singapore)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 13:30~13:50 Early HCC and Treatment with Curative Intent - Has Adjuvant Therapy Opened a New Paradigm? Linda Wong(Univ. of Hawaii, Honululu)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 13:50~14:10 Intermediate-Stage HCC: Re-Defining the Role of Liver-Directed Therapy Hyo-Cheol Kim(Seoul National Univ.)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 14:10~14:30 Intermediate-Stage HCC: Expanding the Role of Systemic Therapy Masafumi Ikeda(National Cancer Center Hospital East, Kashiwa)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 14:30~14:50 Advanced HCC: Novel Approaches beyond Imbrave150 and Himalaya Chih-Hung Hsu(National Taiwan Univ., Taipei)

Åä·Ð 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 14:50~15:05 Q&A Linda Wong, Hyo-Cheol Kim, Masafumi Ikeda, Chih-Hung Hsu(Univ. of Hawaii, Honululu, Seoul National Univ., National Cancer Center Hospital East, Kashiwa, National Taiwan Univ., Taipei)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 15:20~15:45 Investigator-Initiated Trials for HCC in the Asia-Pacific Region Pierce Chow(National Cancer Centre Singapore, Singapore)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 15:45~16:05 Apple Association as a Platform for Future International Research Collaboration Jinsil Seong(Yonsei Univ.)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 16:05~16:25 Promoting the Next-Generation Liver Cancer Experts to the Global Arena Ann-Lii Cheng (National Taiwan Univ. Cancer Center,Taipei)

Åä·Ð 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 16:25~16:40 Q&A Pierce Chow, Jinsil Seong, Ann-Lii Cheng (National Cancer Centre Singapore, Singapore, Yonsei Univ., National Taiwan Univ. Cancer Center,Taipei)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£¾ÏÇÐȸ APPLE 2023 (The 13th Asia-Pacific Primary Liver Cancer Expert Meeting) - Day1 : 2023-07-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û APCCMI 2023 & ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ Á¦26Â÷ Çмú´ëȸ (1ÀÏÂ÷) : 2023-07-06
´ÙÀ½±Û 2023 ´ëÇѽÅÀåÇÐȸ ºÎ¿ï°æÁöȸ Á¦ 108Â÷ ¿¬¼ö±³À° : 2023-07-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
120 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø 2018³â È£½ºÇǽºÀÇ·á±â°ü Á¾»çÀÚ º¸¼ö±³À°°úÁ¤ : 2018-08-25 0 1,441 2018-07-28
119 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ±³À°ÀÚ ¼¼¹Ì³ª : 2018-08-25 0 666 2018-07-28
118 ¼­¿ï Çѱ¹À¯¹æ¾ÏÇÐȸ 2018 School of Breast Disease(Day 1) : 2018-08-25 0 578 2018-07-28
117 ´ëÀü ´ëÇѳëÀκ´ÇÐȸ ³ëÀÎȯÀÚÀÇ Ä¡·á¿Í º¯È­ÇÏ´Â ÀÇ·á : 2018-08-25 0 1,182 2018-07-28
116 ºÎ»ê 2018³â ´ëÇÑÁßȯÀÚÀÇÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ NIV ¿öÅ©¼¥ : 2018-08-25 0 892 2018-07-28
115 ÀÎõ 2018³â ´ëÇѺҾÈÀÇÇÐȸ Çϰ迬¼ö±³À° : 2018-08-25 0 619 2018-07-28
114 ¼­¿ï Çѱ¹¿©ÀÚÀÇ»çȸ ¿°Áõ¼º Àå Áúȯ Áø´Ü°ú Ä¡·á / ³»½Ã°æ ¹ßÀü ¿ª»ç : 2018-08-25 0 539 2018-07-28
113 ´ë±¸ ´ëÇѵÎÅëÇÐȸ ´ë±¸, °æºÏÁö¿ª º¸¼ö±³À°(¸¸¼ºÆíµÎÅë Áø´Ü ¹× Ä¡·á 6 ´Ü°è) : 2018-08-25 0 757 2018-07-28
112 °æ±â Á¦ 7ȸ ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¿ò : 2018-08-25 0 611 2018-07-28
111 ¼­¿ï Á¦2ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¼Ò¾Æ±â°èȯ±â ¿öÅ©¼ó ¿ÀÀü session(8.25) : 2018-08-25 0 998 2018-07-28
110 ¼­¿ï Á¦2ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¼Ò¾Æ±â°èȯ±â ¿öÅ©¼ó Interactive workshop(8.25) : 2018-08-25 0 700 2018-07-28
109 ±¤ÁÖ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Á¦99Â÷ Àü³²ºÏÁöȸ ¿¬¼ö°­Á : 2018-08-25 0 621 2018-07-28
108 ºÎ»ê ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ East Asian Conference of Neurointervention 2018 : 2018-08-25 0 255 2018-07-28
107 ¼­¿ï 2018³â Á¦11ȸ ¼­¿ï´ëÇб³º´¿ø ÀçÈ°ÀÇÇаú ¿¬¼ö°­Á : 2018-08-25 0 542 2018-07-28
106 ¼­¿ï 2018³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ(8/25) : 2018-08-25 0 267 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷